- Home
- SRPT vs NMIH Comparison
SRPT vs NMIH Comparison
Compare SRPT & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | NMIH |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SRPT | NMIH |
|---|---|---|
| Price | $22.77 | $37.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 4 |
| Target Price | $25.40 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 3.2M | 339.9K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.06 |
| EPS | N/A | ★ 4.92 |
| Revenue | ★ $2,198,237,000.00 | $706,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.34 |
| P/E Ratio | ★ N/A | $7.63 |
| Revenue Growth | ★ 15.58 | 8.52 |
| 52 Week Low | $10.42 | $32.71 |
| 52 Week High | $64.80 | $43.20 |
Technical Indicators
Market Signals| Indicator | SRPT | NMIH |
|---|---|---|
| Relative Strength Index (RSI) | 64.87 | 46.67 |
| Support Level | $20.61 | $36.53 |
| Resistance Level | $23.51 | $38.04 |
| Average True Range (ATR) | 1.30 | 0.72 |
| MACD | 0.59 | 0.09 |
| Stochastic Oscillator | 85.75 | 71.48 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.